Argent BioPharma Limited (ASX:RGT – Get Free Report) insider Roby Zomer bought 4,000,000 shares of the firm’s stock in a transaction dated Tuesday, October 15th. The stock was bought at an average cost of A$0.41 ($0.28) per share, with a total value of A$1,640,000.00 ($1,100,671.14).
Roby Zomer also recently made the following trade(s):
- On Tuesday, September 10th, Roby Zomer bought 1,258,500 shares of Argent BioPharma stock. The stock was bought at an average cost of A$0.40 ($0.27) per share, with a total value of A$503,400.00 ($337,852.35).
Argent BioPharma Stock Performance
About Argent BioPharma
Further Reading
- Five stocks we like better than Argent BioPharma
- What Are the U.K. Market Holidays? How to Invest and Trade
- Survey Reveals: America’s Most Coveted Businesses in 2024
- Airline Stocks – Top Airline Stocks to Buy Now
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- How Technical Indicators Can Help You Find Oversold Stocks
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Argent BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Argent BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.